Entrada Therapeutics
TRDA
TRDA
112 hedge funds and large institutions have $269M invested in Entrada Therapeutics in 2025 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 42 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
11.02% less ownership
Funds ownership: 79.44% → 68.41% (-11%)
21% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 42
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
112
Holding in Top 10
3
Calls
$229K
Puts
$113K
Top Buyers
| 1 | +$12.7M | |
| 2 | +$1.74M | |
| 3 | +$1.2M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$935K |
| 5 |
BlackRock
New York
|
+$870K |
Top Sellers
| 1 | -$2.88M | |
| 2 | -$2.86M | |
| 3 | -$1.69M | |
| 4 |
Jane Street
New York
|
-$1.36M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.02M |
